SHIFT Newsroom · GLOBAL
Why researchers study both activating and blocking the GIP receptor
An Appetite review explores two approaches to obesity research without declaring a winner.
What the review explains
GIP-receptor agonism activates the receptor; antagonism blocks its activity. The authors examine why both approaches are being investigated alongside GLP-1 signalling.
They discuss proposed effects on appetite-related brain pathways, energy use and tolerability. For antagonism, they consider interaction with GLP-1 effects and the fat-storage actions of the body’s own GIP.
What remains uncertain
This is a synthesis of mechanisms and existing evidence, not a new head-to-head trial establishing the better approach. Effects can depend on the molecule, dose, study population and outcomes measured. Mechanistic plausibility is not the same as demonstrated long-term clinical benefit.
SHIFT’s take
Apparently opposite mechanisms can both warrant research. That is a reason to examine comparative patient evidence—not rank medicines by the number of receptors mentioned in a headline.
Known facts
- The source is a review in Appetite.